Home/Filings/4/0001062993-24-020285
4//SEC Filing

Gillheeney Gary S. 4

Accession 0001062993-24-020285

CIK 0001661181other

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 8:05 PM ET

Size

10.9 KB

Accession

0001062993-24-020285

Insider Transaction Report

Form 4
Period: 2024-12-05
Gillheeney Gary S.
DirectorPresident and CEO
Transactions
  • Sale

    Class A Common Stock

    2024-12-09$3.52/sh41,052$144,5033,359,726 total
  • Exercise/Conversion

    Class A Common Stock

    2024-12-05$0.99/sh+1,067,245$1,056,5733,419,194 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-12-051,067,2450 total
    Exercise: $0.99Exp: 2024-12-08Class A Common Stock (1,067,245 underlying)
  • Sale

    Class A Common Stock

    2024-12-06$3.65/sh18,416$67,2183,400,778 total
Footnotes (4)
  • [F1]The reported disposition represents the sale of shares to cover the withholding tax that was previously paid to the issuer arising from the exercise of the expiring stock option reported above.
  • [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.6132 to $3.6858, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.48 to $3.69, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
  • [F4]100% of the shares subject to the option are fully vested and exercisable.

Issuer

Organogenesis Holdings Inc.

CIK 0001661181

Entity typeother

Related Parties

1
  • filerCIK 0001757373

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 8:05 PM ET
Size
10.9 KB